Breast Cancer. Malignant neoplasm of breast
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who are aware of their disease diagnosis. Patients who have the ability to speak and communicate verbally. Patients who are interested in participating in the study. Cancer patients who have been diagnosed for at least one month Patients who have completed at least two chemotherapy sessions.
Exclusion criteria
Exclusion criteria: Patients with mental retardation, blindness, deafness, physical problems and mobility disabilities Patients with any metastases. Patients who are treated with anticoagulant drugs. Patients who have been treated with radiotherapy before chemotherapy. Patients who have a history of any type of cancer other than breast cancer.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The score obtained from the general self-efficacy questionnaire. Timepoint: Immediately before and immediately after the intervention. Method of measurement: Sherer General Self-Efficacy Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| The score obtained from Depression, anxiety and stress questionnaire DASS-42. Timepoint: Immediately before and immediately after the intervention. Method of measurement: Depression, anxiety and stress questionnaire DASS-42. | — |
Countries
Iran (Islamic Republic of)
Contacts
Esfahan University of Medical Sciences